-
Healing Through Art
The Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.
by Ashley P. Taylor
-
Brain Cancer Patients Make Connections
An app developed for glioblastoma patients allows them to track their symptoms and contribute to research.
by Brad Jones
-
Paying for Tumor Testing
A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.
by Brad Jones
-
AACR Annual Meeting 2018
A roundup of news from the American Association for Cancer Research Annual Meeting 2018.
-
The Ins and Outs of Tumor Testing
In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
The Many Faces of Patient Advocacy
Advocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
Focusing on the Fundamentals
National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
-
A Response to Roadblocks
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
-
Supporting Survivors
Panel of experts discuss survivorship challenges and potential areas for study.
by Marci A. Landsmann
-
Artificial Intelligence Characterizes Cancer
At the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer.
by Kevin McLaughlin
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon